Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands; ICIN-Netherlands Heart Institute, Utrecht, the Netherlands.
JACC Heart Fail. 2017 Jan;5(1):14-24. doi: 10.1016/j.jchf.2016.09.015.
The study sought to compare the prevalence, clinical correlates and prognostic impact of diabetes in Southeast Asian versus white patients with heart failure (HF) with preserved or reduced ejection fraction.
Diabetes mellitus is common in HF and is associated with impaired prognosis. Asia is home to the majority of the world's diabetic population, yet data on the prevalence and clinical significance of diabetes in Asian patients with HF are sparse, and no studies have directly compared Asian and white patients.
Two contemporary population-based HF cohorts were combined: from Singapore (n = 1,002, median [25th to 75th percentile] age 62 [54 to 70] years, 76% men, 19.5% obesity) and Sweden (n = 19,537, 77 [68 to 84] years, 60% men, 24.8% obesity). The modifying effect of ethnicity on the relationship between diabetes and clinical correlates or prognosis (HF hospitalization and all-cause mortality) was examined using interaction terms.
Diabetes was present in 569 (57%) Asian patients versus 4,680 (24%) white patients (p < 0.001). Adjusting for clinical covariates, obesity was more strongly associated with diabetes in white patients (odds ratio [OR]: 3.45; 95% confidence interval [CI]: 2.86 to 4.17) than in Asian patients (OR: 1.82; 95% CI: 1.13 to 2.96; p = 0.026). Diabetes was more strongly associated with increased HF hospitalization and all-cause mortality in Asian patients (hazard ratio: 1.50; 95% CI: 1.21 to 1.87) than in white patients (hazard ratio: 1.29; 95% CI: 1.22 to 1.36; p = 0.045).
Diabetes was 3-fold more common in Southeast Asian compared to white patients with HF, despite younger age and less obesity, and more strongly associated with poor outcomes in Asian patients than white patients. These results underscore the importance of ethnicity-tailored aggressive strategies to prevent diabetes and its complications.
本研究旨在比较东南亚裔与白种人心力衰竭(HF)伴射血分数保留或降低患者中糖尿病的患病率、临床相关性及预后影响。
糖尿病在 HF 中很常见,与预后不良有关。亚洲是世界上大多数糖尿病患者的所在地,但亚洲 HF 患者中糖尿病的患病率和临床意义的数据很少,且尚无研究直接比较亚洲患者和白种人患者。
合并两个当代基于人群的 HF 队列:新加坡队列(n=1002,中位[25 至 75 百分位]年龄 62[54 至 70]岁,76%为男性,19.5%为肥胖)和瑞典队列(n=19537,77[68 至 84]岁,60%为男性,24.8%为肥胖)。使用交互项检验种族对糖尿病与临床相关性或预后(HF 住院和全因死亡率)之间关系的修饰作用。
569 例(57%)亚洲患者存在糖尿病,4680 例(24%)白种患者存在糖尿病(p<0.001)。调整临床协变量后,肥胖与白种患者的糖尿病相关性更强(比值比[OR]:3.45;95%置信区间[CI]:2.86 至 4.17),而与亚洲患者的相关性较弱(OR:1.82;95% CI:1.13 至 2.96;p=0.026)。与白种患者相比,糖尿病与亚洲患者 HF 住院和全因死亡率增加的相关性更强(风险比:1.50;95% CI:1.21 至 1.87),与白种患者的相关性较弱(风险比:1.29;95% CI:1.22 至 1.36;p=0.045)。
与白种人相比,东南亚裔 HF 患者中糖尿病的患病率高 3 倍,尽管年龄较小且肥胖程度较低,但与亚洲患者的不良结局相关性更强。这些结果强调了针对特定种族的强化策略预防糖尿病及其并发症的重要性。